永鴻國際生技股份有限公司
永鴻國際生技股份有限公司為永信集團旗下動物藥品大廠。產品線涵蓋動物藥品(抗感染、代謝促進劑)、機能性飼料添加劑及寵物保健品,為台灣畜牧業與水產業提供完整的動物健康解決方案。公司成立於 2012 年,總部位於台灣台中。
該股 RSI(6) 為 60.8,處於中性區間,短線無明顯超買超賣訊號。股價站上5日、20日均線,跌破60日、120日均線。短中期均線呈空頭排列,趨勢偏空。KD 指標中性(K=46.1);MACD 柱狀體為正值,維持多方動能。 (自動產生 · 非投資建議)
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-07 | +3 | 0 | -2 | +1 |
| 08-06 | +1 | 0 | 0 | +1 |
| 08-05 | -5 | 0 | -1 | -6 |
| 08-04 | +1 | 0 | -5 | -4 |
| 08-03 | +6 | 0 | -1 | +5 |
| 07-31 | +1 | 0 | 0 | +1 |
| 07-30 | 0 | 0 | 0 | 0 |
| 07-29 | +10 | 0 | +1 | +11 |
| 07-28 | +1 | 0 | +2 | +3 |
| 07-27 | +5 | 0 | 0 | +5 |
| 07-24 | -1 | 0 | 0 | -1 |
| 07-23 | -3 | 0 | 0 | -3 |
| 07-22 | -2 | 0 | -1 | -3 |
| 07-21 | +2 | 0 | 0 | +2 |
| 07-20 | +1 | 0 | +1 | +2 |
| 07-17 | +2 | 0 | +1 | +3 |
| 07-16 | -2 | 0 | 0 | -2 |
| 07-15 | +2 | 0 | -3 | -1 |
| 07-14 | +1 | 0 | +2 | +3 |
| 07-13 | -7 | 0 | 0 | -7 |
| 07-09 | +14 | 0 | 0 | +14 |
| 07-08 | +1 | 0 | 0 | +1 |
| 07-07 | -2 | 0 | -2 | -4 |
| 07-06 | +18 | 0 | 0 | +18 |
| 07-03 | 0 | 0 | +2 | +2 |
| 07-02 | 0 | 0 | 0 | 0 |
| 07-01 | -1 | 0 | 0 | -1 |
| 06-30 | -2 | 0 | 0 | -2 |
| 06-29 | +2 | 0 | 0 | +2 |
| 06-26 | -17 | 0 | 0 | -17 |
| 06-25 | -2 | 0 | 0 | -2 |
| 06-24 | +2 | 0 | +1 | +3 |
| 06-22 | +3 | 0 | 0 | +3 |
| 06-18 | -2 | 0 | 0 | -2 |
| 06-17 | -1 | 0 | 0 | -1 |
| 06-16 | +5 | 0 | 0 | +5 |
| 06-15 | +3 | 0 | 0 | +3 |
| 06-12 | -1 | 0 | +4 | +3 |
| 06-10 | -12 | 0 | 0 | -12 |
| 06-09 | -1 | 0 | -7 | -8 |
| 06-08 | -9 | 0 | 0 | -9 |
| 06-04 | +3 | 0 | 0 | +3 |
| 06-03 | +3 | 0 | 0 | +3 |
| 06-02 | +2 | 0 | 0 | +2 |
| 06-01 | +12 | 0 | 0 | +12 |
| 05-29 | +7 | 0 | 0 | +7 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 1.17 億 | -7.0% | -0.4% |
| 2026/05 | 1.26 億 | -4.6% | +19.3% |
| 2026/04 | 1.32 億 | -0.0% | +27.2% |
| 2026/03 | 1.32 億 | +43.3% | +15.7% |
| 2026/02 | 9233 萬 | -35.8% | -11.7% |
| 2026/01 | 1.44 億 | +19.7% | - |
| 2025/12 | 1.20 億 | -10.4% | - |
| 2025/11 | 1.34 億 | +13.3% | - |
| 2025/10 | 1.18 億 | -5.3% | - |
| 2025/09 | 1.25 億 | +3.1% | - |
| 2025/08 | 1.21 億 | -5.7% | - |
| 2025/07 | 1.29 億 | - | - |